v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Earnings (Loss)
Noncontrolling Interest (NCI)
Total
Beginning balance at Dec. 28, 2024 $ 60,724 $ 403,379 $ 2,775,280 $ (15,311) $ 20,553 $ 3,244,625
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     78,753   853 79,606
Foreign currency translation adjustment       2,744 (31) 2,713
Unrealized gain on debt securities       470   470
Other   (355)       (355)
Cash dividends     (21,322)     (21,322)
Issuance of shares under employee stock purchase plan 7 643       650
Issuance of shares under stock grant programs 232 3,055 101     3,388
Issuance of shares under deferred compensation plans 81 (81)        
Repurchase of shares (649) (9,460) (59,991)     (70,100)
Expense associated with share-based compensation arrangements   11,493       11,493
Accrued expense under deferred compensation plans   7,888       7,888
Ending balance at Mar. 29, 2025 60,395 416,562 2,772,821 (12,097) 21,375 3,259,056
Beginning balance at Dec. 27, 2025 56,592 444,828 2,559,375 1,564 21,885 3,084,244
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     50,774   305 51,079
Foreign currency translation adjustment       (1,220) (6) (1,226)
Unrealized gain on debt securities       382   382
Distributions to NCI         (1,082) (1,082)
Other   (167)       (167)
Cash dividends     (20,456)     (20,456)
Issuance of shares under employee stock purchase plan 8 570       578
Issuance of shares under stock grant programs 144 1,896 38     2,078
Issuance of shares under deferred compensation plans 71 (71)        
Repurchase of shares (335) (1,193) (28,501)     (30,029)
Expense associated with share-based compensation arrangements   8,409       8,409
Accrued expense under deferred compensation plans   6,881       6,881
Ending balance at Mar. 28, 2026 $ 56,480 $ 461,153 $ 2,561,230 $ 726 $ 21,102 $ 3,100,691